US Stock IR Daily – July 16, 2026 (8 reports)

• UnitedHealth Group Incorporated announced its second quarter 2026 results on July 16, 2026.
• A press release detailing the earnings announcement was furnished as Exhibit 99.1.
• The press release also included a hyperlink to a PDF document, furnished as Exhibit 99.2.
• These documents were filed with the U.S. Securities and Exchange Commission (SEC) via a Form 8-K on July 16, 2026.

UnitedHealth’s announcement of its second quarter 2026 results provides investors with official information regarding the company’s recent financial performance and operational status. The press release and accompanying PDF document are expected to detail key financial metrics such as revenues, earnings, and other relevant indicators. This information could be crucial for stakeholders assessing the company’s current health and potential future trajectory.

• GE Aerospace (General Electric Company) released its second-quarter 2026 financial results on July 16, 2026.
• The financial results were made available on the company’s investor relations website at www.geaerospace.com/investor-relations.
• The announcement was filed with the U.S. Securities and Exchange Commission as Item 2.02, “Results of Operations and Financial Condition,” on Form 8-K.
• A copy of these results is attached as Exhibit 99 and incorporated by reference into the filing.

GE Aerospace’s announcement of its Q2 2026 financial results provides current and prospective investors with crucial data to assess the company’s recent performance. The availability of this information on their investor relations website may suggest a commitment to transparency and accessibility for stakeholders. Investors will likely scrutinize the detailed financial figures to understand the company’s operational health and future trajectory.

• U.S. Bancorp issued a press release on July 16, 2026, reporting financial results for the quarter ended June 30, 2026.
• The press release is attached as Exhibit 99.1, and supplemental materials (the “2Q26 Earnings Supplement”) are attached as Exhibit 99.2 to the Form 8-K filing.
• These materials, including the 2Q26 Earnings Supplement, have also been made available on the Company’s website.
• The press release contains forward-looking statements and a cautionary statement identifying factors that could cause actual results to differ materially.

U.S. Bancorp’s latest quarterly earnings release provides critical information for investors to assess the company’s recent financial performance. A detailed review of the press release and supplemental materials may offer insights into key financial metrics such as revenues, expenses, and loan loss provisions, which could indicate the company’s operational health and future outlook. The inclusion of forward-looking statements and cautionary language suggests the importance of considering potential risks and uncertainties alongside the reported figures.

• On July 16, 2026, Abbott Laboratories announced its results of operations for the second quarter of 2026.
• This announcement was disclosed via a Form 8-K filed with the U.S. Securities and Exchange Commission (SEC).
• Detailed financial results for the quarter are provided in a news release, furnished as Exhibit 99.1 to the Form 8-K filing.
• The news release includes various non-GAAP financial measures, such as net earnings excluding specified items.
• These non-GAAP measures adjust for factors like expenses primarily associated with acquisitions, legal reserves, restructuring actions, certain regulatory costs, and tax benefits related to share-based compensation, among others.

Abbott Laboratories’ Q2 2026 earnings announcement provides key insights into the company’s recent financial performance. The inclusion of non-GAAP financial measures suggests an attempt to offer a clearer view of the company’s operational results by excluding factors considered unusual or unpredictable. Investors may find it beneficial to analyze both GAAP and non-GAAP figures to gain a comprehensive understanding of the company’s underlying business trends.

• Prologis, Inc. and Prologis, L.P. filed a Form 8-K dated July 16, 2026.
• The report relates to a press release issued by Prologis, Inc. on July 16, 2026, announcing its Second Quarter 2026 financial results.
• Supplemental information and the press release concerning the Second Quarter 2026 financial results are furnished as Exhibit 99.1 and Exhibit 99.2, respectively, and incorporated by reference.
• Prologis, Inc. is incorporated in Maryland, and Prologis, L.P. is incorporated in Delaware.
• Prologis, Inc. Common Stock (PLD), Prologis, L.P. 2.250% Notes due 2029 (PLD/29), and Prologis, L.P. 5.625% Notes due 2040 (PLD/40) are all registered on the New York Stock Exchange.

Prologis has released its Second Quarter 2026 financial results, providing investors with updated information on its performance. The filing of the Form 8-K signals the public disclosure of these results and accompanying materials. Reviewing the supplemental information and press release could offer key insights into the company’s operational and financial health, which may be relevant for investors monitoring the real estate investment trust sector.

• Netflix, Inc. announced its financial results for the quarter ended June 30, 2026, on July 16, 2026.
• The announcement was made through a Form 8-K filing with the U.S. Securities and Exchange Commission (SEC).
• The Form 8-K included a Letter to Shareholders (Exhibit 99.1), which references non-GAAP financial information and provides a reconciliation to GAAP equivalents.
• The company stated that it is unable to reconcile forward-looking non-GAAP financial measures to GAAP equivalents due to the unpredictability of reconciling items and currency exchange rate impacts.
• The report was signed by Spencer Neumann, Chief Financial Officer of Netflix, Inc.

Netflix’s release of its Q2 2026 financial results provides investors with the latest performance data to assess the company’s operational health. The inclusion of non-GAAP financial information in the Letter to Shareholders, along with its GAAP reconciliation, offers insight into management’s view of core business performance. The commentary regarding the difficulty in reconciling forward-looking non-GAAP measures may suggest a degree of uncertainty regarding future financial projections, which could be a point of focus for analysts.

• Intuitive Surgical, Inc. filed a Form 8-K on July 16, 2026.
• The Form 8-K announced the company’s financial results for the quarter ended June 30, 2026.
• A press release detailing these results was issued on July 16, 2026, and furnished as Exhibit 99.1 to the Form 8-K.
• Jamie E. Samath, Executive Vice President, Chief Financial Officer, signed the report on July 16, 2026.

This announcement indicates that Intuitive Surgical has disclosed its financial performance for the most recent quarter to the market. The accompanying press release (Exhibit 99.1) is expected to provide specific details regarding the company’s financial condition and operational activities. Quarterly earnings reports are key indicators of a company’s health and growth trajectory, and investors may monitor this information for insights into its performance.

• On July 16, 2026, The Coca-Cola Company announced that its dairy company, fairlife, LLC, identified unauthorized third-party access to a portion of its systems, including production-related systems, in connection with a ransomware event.
• Upon detection, the Company promptly activated its incident response and business continuity protocols.
• The Company’s investigation and assessment of the incident’s impact are ongoing, with the assistance of outside advisors and cybersecurity experts. Law enforcement has also been notified.
• Product quality and safety have not been impacted by the incident.
• As a result of the incident, fairlife’s production operations in the United States are temporarily suspended. fairlife’s Canada production operations are not currently impacted.

The ransomware event at fairlife, a subsidiary of Coca-Cola, highlights the increasing cyber security risks within supply chains. While the confirmation that product quality and safety remain unaffected is crucial for consumer confidence, the temporary suspension of U.S. production could potentially impact short-term supply and operational performance. Investors may find it worthwhile to monitor how quickly the company restores its systems and implements enhanced security measures to mitigate future risks.